Browsing by Subject "alkaline phosphatase"

Acute hypoadrenocorticism (adrenal crisis) in the dog:a report on six clinical cases [Οξύς υποφλοιοεπινεφριδισμος (αδισσώνια κρίση) στο σκύλο:αναφορά σε έξι περιστατικά]

Kasabalis D., Soubasis N., Pardali D., Savas I., Pavlidou K., Petanides T.A., Papadimitriou D., Variami V., Koutinas A.F. (2017)

Medical records of six dogs admitted with acute hypoadrenocorticism were reviewed. All 6 animals were bradycardic and had prolonged capillary refilling time. Hypothermia was detected in 5/6 animals. Clinicopathological ...

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars

Zachou K., Azariadis K., Sofia M., Lyberopoulou A., Arvaniti P., Gatselis N., Spyrou V., Billinis C., Dalekos G.N. (2022)

Background Hepatitis E virus (HEV) infection incidence is increasing in Europe, accounting for the majority of acute hepatitis cases. We investigated the prevalence and clinical characteristics of acute hepatitis E (AHE) ...

Anemia associated with autoimmune liver disease in a middle-aged female

Karakousis N.D., Kolonia V., Saltamavros A.D., Ntellas P., Kaligeros K. (2019)

Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) can coexist as a variant syndrome of autoimmune liver disease. The case is reported of a 49-year-old woman with anemia and ascites, in whom laboratory tests ...

Biomarkers in prostate-specific membrane antigen theranostics

Vlachostergios P.J., Zachos I., Tzortzis V. (2021)

Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA). In view of the ...

A controlled trial of polyglytone 6211 versus poliglecaprone 25 for use in intradermal suturing in dogs

Gouletsou P., Prassinos N., Papazoglou L., Kostoulas P., Galatos A. (2021)

The objective of this work was the comparative evaluation of the healing process after em-ploying 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in ...

Decreased serum DNase1-activity in patients with autoimmune liver diseases

Gatselis N.K., Vakrakou A.G., Zachou K., Androutsakos T., Azariadis K., Hatzis G., Manoussakis M.N., Dalekos G.N. (2017)

Deoxyribonuclease1 (DNase1) is involved in chromatin degradation of apoptotic cells. Its deficiency results in accumulation of self-DNA, which in turn may induce inflammation and autoimmunity. We assessed for the first ...

Discrimination of exudative pleural effusions based on pleural adenosine deaminase (Ada)-c-reactive protein (crp) levels, and their combination: An observational prospective study

Perlepe G., Varsamas C., Petinaki E., Antonopoulos D., Daniil Z., Gourgoulianis K.I. (2021)

(1) Background: Malignant (MPE), parapneumonic (PPE) and tuberculous (TPE) pleural effusions constitute common causes of pleurisy. Discriminating among them is usually challenging. C-reactive protein (CRP) and adenosine ...

Early primary biliary cirrhosis: A new association with erythema nodosum of unknown origin

Dalekos, G. N.; Gatselis, N. K.; Zachou, K. (2010)

Primary biliary cirrhosis (PBC) is associated with immune-mediated dermatologic disorders. The association of PBC with erythema nodosum (EN) seems rare. We report two females (42 and 44 years old) with low-grade fever, ...

The effects of calcitonin on acute bone loss after pertrochanteric fractures. A prospective, randomised trial

Karachalios, T.; Lyritis, G. P.; Kaloudis, J.; Roidis, N.; Katsiri, M. (2004)

We investigated the effect of calcitonin in the prevention of acute bone loss after a pertrochanteric fracture and its ability to reduce the incidence of further fractures in the same patient. Fifty women aged between 70 ...

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Gatselis N.K., Goet J.C., Zachou K., Lammers W.J., Janssen H.L.A., Hirschfield G., Corpechot C., Lindor K.D., Invernizzi P., Mayo M.J., Battezzati P.M., Floreani A., Pares A., Lygoura V., Nevens F., Mason A.L., Kowdley K.V., Ponsioen C.Y., Bruns T., Thorburn D., Verhelst X., Harms M.H., van Buuren H.R., Hansen B.E., Dalekos G.N., Global Primary Biliary Cholangitis Study Group (2020)

Background & Aims: Patients usually receive a diagnosis of primary biliary cholangitis (PBC) at an early stage, based on biochemical analyses. We investigated the proportion of patients who progress to moderate or advanced ...

Fanconi syndrome in the adulthood. The role of early diagnosis and treatment

Karatzas A.D., Paridis D., Kozyrakis D., Tzortzis V., Samarinas M., Dailiana Z., Karachalios T. (2017)

[No abstract available]

Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia

Stefanopoulos D., Nasiri-Ansari N., Dontas I., Vryonidou A., Galanos A., Psaridi L., Fatouros I.G., Mastorakos G., Papavassiliou A.G., Kassi E., Tournis S. (2020)

Derangements in phosphate and calcium homeostasis are common in patients with beta-thalassemia. Fibroblast growth factor 23 (FGF23) is among the main hormones regulating phosphate levels, while several studies underline ...

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus

Azariadis K., Gatselis N.K., Koukoulis G.K., Dalekos G.N. (2019)

Glycogenic hepatopathy (GH) is a rare complication of poorly controlled type 1 diabetes mellitus (T1DM). We present a 19-year-old woman with T1DM and autoimmune thyroiditis who admitted to our department because of abrupt ...

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin within the Normal Range and Normalization of Alkaline Phosphatase

Murillo Perez C.F., Harms M.H., Lindor K.D., Van Buuren H.R., Hirschfield G.M., Corpechot C., Van Der Meer A.J., Feld J.J., Gulamhusein A., Lammers W.J., Ponsioen C.Y., Carbone M., Mason A.L., Mayo M.J., Invernizzi P., Battezzati P.M., Floreani A., Lleo A., Nevens F., Kowdley K.V., Bruns T., Dalekos G.N., Gatselis N.K., Thorburn D., Trivedi P.J., Verhelst X., Parés A., Janssen H.L.A., Hansen B.E. (2020)

INTRODUCTION:In primary biliary cholangitis (PBC), bilirubin and alkaline phosphatase (ALP) are widely established as independent predictors of prognosis. Current treatment goals do not aim for normalization of surrogate ...

Green remediation of toxic metals contaminated mining soil using bacterial consortium and Brassica juncea

Jeyasundar P.G.S.A., Ali A., Azeem M., Li Y., Guo D., Sikdar A., Abdelrahman H., Kwon E., Antoniadis V., Mani V.M., Shaheen S.M., Rinklebe J., Zhang Z. (2021)

Microorganism-assisted phytoremediation is being developed as an efficient green approach for management of toxic metals contaminated soils and mitigating the potential human health risk. The capability of plant growth ...

Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: Consider primary biliary cholangitis not always primary sclerosing cholangitis

Polychronopoulou E., Lygoura V., Gatselis N.K., Dalekos G.N. (2017)

Several hepatobiliary disorders have been reported in ulcerative colitis (UC) patients with primary sclerosing cholangitis (PSC) being the most specific. Primary biliary cholangitis (PBC), previously known as primary biliary ...

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

Murillo Perez C.F., Goet J.C., Lammers W.J., Gulamhusein A., van Buuren H.R., Ponsioen C.Y., Carbone M., Mason A., Corpechot C., Invernizzi P., Mayo M.J., Battezzati P.M., Floreani A., Pares A., Nevens F., Kowdley K.V., Bruns T., Dalekos G.N., Thorburn D., Hirschfield G., LaRusso N.F., Lindor K.D., Zachou K., Poupon R., Trivedi P.J., Verhelst X., Janssen H.L.A., Hansen B.E., on behalf of the GLOBAL PBC Study Group (2018)

Changes over time in the presenting features and clinical course of patients with primary biliary cholangitis are poorly described. We sought to describe temporal trends in patient and disease characteristics over a 44-year ...